Linda Shapiro Manning - Sep 10, 2021 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Chief Medical Officer
Signature
/s/ Hunter Smith, attorney-in-fact for Linda Shapiro Manning
Stock symbol
RYTM
Transactions as of
Sep 10, 2021
Transactions value $
$0
Form type
4
Date filed
9/15/2021, 06:51 PM
Next filing
Feb 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Stock Option (Right to Buy) Award $0 +15K $0.00 15K Sep 10, 2021 Common Stock 15K $12.98 Direct F1
transaction RYTM Restricted Stock Units Award $0 +2.5K $0.00 2.5K Sep 10, 2021 Common Stock 2.5K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were granted on September 10, 2021. 25% of the shares subject to the option will vest and become exercisable on September 10, 2022 and the remaining 75% of the shares subject to the option shall vest and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter.
F2 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F3 The restricted stock units vest as to 25% of the total shares on each of September 10, 2022, September 10, 2023, September 10, 2024 and September 10, 2025. The restricted stock units have no expiration date.